Using a MEMO wearable patch to find atrial fibrillation after an unexplained stroke

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, single-center exploratory trial enrolling about 100 adults with embolic stroke of undetermined source (ESUS). Participants will undergo in-hospital telemetry monitoring with the MEMO Patch M and MEMO Cue for 12 hours up to 8 days alongside a 24-hour Holter, and investigators will review results to decide if an implantable loop recorder (ILR) is needed. At discharge all participants will wear MEMO Patch2 for up to 14 days for outpatient ECG monitoring, and results will be reviewed about one month later. The protocol is designed to determine how well the wearable patches detect previously undiagnosed atrial fibrillation and to inform ILR use.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Participants may take part in this clinical study only if they meet all of the following criteria:

1. Adults aged 19 years or older who voluntarily provide written informed consent to participate in the study
2. Patients diagnosed with ESUS (Embolic Stroke of Undetermined Source)
3. Patients who require in-hospital or out-of-hospital electrocardiographic (ECG) monitoring

Exclusion Criteria:

Participants who meet any of the following criteria cannot be enrolled in this clinical study:

1. Individuals already diagnosed with atrial fibrillation or atrial flutter
2. Individuals with a clearly identified cause of stroke
3. Individuals known to have allergic reactions to adhesives or hydrogels
4. Individuals who, in the investigator's judgment, have cognitive vulnerability that makes it difficult to understand the study information and voluntarily decide on participation
5. Any other individuals whom the principal investigator considers to be at potential risk by participating in the study or otherwise unsuitable for participation

Where it's running

• Asan Medical Center
  Seoul, Songpa-gu, South Korea Recruiting

Study contacts

• Principal investigator: Bum Joon Kim — Asan Medical Center
• Study coordinator: Bum Joon Kim
• Email: medicj80@hanmail.net
• Phone: +82 02-3010-3981

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• PFO closure versus blood thinners to prevent repeat stroke in older adults

  This study will test whether closing a patent foramen ovale or taking direct oral anticoagulants better prevents repeat strokes in adults over 60 with PFO-related embolic stroke.

  Recruiting at 3 sites Taichung Veterans General Hospital · Taichung and 2 other locations · NCT07479147

• AI analysis of ECGs to predict atrial fibrillation risk in ESUS patients with an implantable cardiac monitor.

  This project tests whether an AI tool called SmartECG-AF can use a routine 12-lead ECG to predict which ESUS patients with an implantable cardiac monitor will develop atrial fibrillation.

  Recruiting at 5 sites Inha University Hospital · Ansan and 4 other locations · NCT07347691

• Left atrial function in people with unexplained (cryptogenic) stroke.

  This will see if lower left atrial strain on a heart ultrasound is linked to unexplained (cryptogenic) stroke and to higher risk of another stroke in adults who had a stroke without a known cause.

  Recruiting University of Pittsburgh · Pittsburgh, Pennsylvania · NCT07224178

• High-coverage carotid stent versus medical treatment to prevent embolism from symptomatic non-stenotic carotid disease (SyNC)

  This trial will test whether placing a high‑coverage carotid stent, compared with medical therapy alone, reduces repeat embolic events in people who recently had symptoms from low‑grade (10–49%) carotid plaques with high‑risk features.

  Recruiting Acandis GmbH · Solingen, North Rhine-Westphalia · NCT07166731

• Investigating the effects of Empagliflozin on heart function after unexplained strokes

  This study is testing if the medication Empagliflozin can help improve heart function and prevent future strokes in people who have had unexplained strokes.

  Recruiting Phase 2/3 University of East Anglia · Cambridge, Cambridgeshire · NCT06715449

• Identifying New Cancer After Ischemic Stroke in High-Risk Patients

  This study is trying to see if people who had an ischemic stroke and have high D-dimer levels are more likely to be diagnosed with hidden cancer within a year.

  Recruiting at 3 sites Insel Gruppe AG, University Hospital Bern · Lausanne, Canton of Vaud and 2 other locations · NCT06100718

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.